Lupin Limited
Search results
Mankind Pharma is one of the Indian leading pharmaceutical companies, and changes the pharma industry by providing world class medications at affordable prices and maintaining quality standards by using state-of-the-art technology for production of high-quality medicines.
11 hours ago · Mankind Pharma, the domestic pharmaceutical major’s stock price surged up to 5.27 per cent at Rs 2,215 per share on the BSE in Wednesday’s intraday trade. According to reports, this came after around 3.7 million shares of Mankind Pharma, equivalent to 0.9 percent equity stake, were sold via block deals totaling Rs 771 crore on Wednesday.
Mankind Pharma is an Indian pharmaceutical and healthcare products company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics , to gastrointestinal , cardiovascular , dermal , and erectile dysfunction medications.
Mankind Pharma focuses on a variety of therapeutic segments such as Cardiovascular, Antibiotics, Gastro-intestinal, Anti-allergic, Anti-fungal, Nutritional, NSAIDs, Ortho and Gynaecological. Every day 75 Lacs Indians consume Mankind's cardiac care products.
12 hours ago · Shares of Mankind Pharma surged 4% to today's high of Rs 2,187.85, while those of Delhivery rose 2% to its day's high of Rs 403.65 on the BSE after a stake was offloaded in the companies via block deals. Hema CIPEF (I), an affiliate of the US-based Capital Group, likely sold a 0.9% stake in Mankind Pharma through block deals, while Canada ...
Mankind Pharma, Best pharmaceutical company in India, has a wide range of products like Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular Dermal, Erectile Dysfunction etc.
13 hours ago · As of the March quarter, Hema CIPEF held a 2.22% stake in Mankind Pharma. At the end of the March quarter, India's domestic mutual funds held an 8.57% stake in Mankind Pharma. Foreign Portfolio Investors too had a 9.87% stake. Mankind Pharma had made its stock market debut in May last year at an IPO price of ₹1,300 per share.
